Sheridan Capital Partners announced on October 7, 2026, the successful closing of two new funds, securing a combined $1.345 billion in institutional capital for investments in the healthcare sector. The private equity firm’s new flagship fund, Sheridan Capital Partners Fund IV, closed at its hard cap of $1.1 billion. In a simultaneous expansion of its strategy, the firm also launched its first dedicated healthcare information technology fund, Healthcare IT Fund I, with $245 million in capital commitments, according to a company press release distributed by Business Wire.
The law firm Kirkland & Ellis advised Sheridan on the closing of both funds. The total capital raised marks a significant expansion of the firm's investment capacity and signals strong investor confidence in its specialized focus on the healthcare industry.
Rapid Fundraising Signals Strong Investor Demand
The fundraising process for the firm's main vehicle, Fund IV, was exceptionally swift, concluding in under 60 days from its launch. According to Sheridan's announcement, the fund was "meaningfully oversubscribed," a term indicating that investor demand for a stake in the fund exceeded the firm's $1.1 billion limit, or hard cap. This high level of interest came from both new and returning institutional investors.
Sheridan Capital Partners attributed the strong reception to its "disciplined and thesis-driven healthcare investment strategy." The rapid and oversubscribed closing in a competitive market underscores the appeal of the firm's established track record and its focus on specific segments within the healthcare industry.
Flagship Fund IV Nearly Doubles Predecessor
The $1.1 billion raised for Fund IV represents a substantial increase in scale for Sheridan's flagship investment vehicle. The amount is nearly double the $575 million the firm raised for its predecessor, Sheridan Capital Partners Fund III, which closed at its hard cap in July 2023. This significant growth in capital allows the firm to pursue a broader range of opportunities and potentially larger deals.
According to information from its legal advisor, Kirkland & Ellis, Fund IV will continue Sheridan's strategy of investing in businesses across the healthcare landscape. Its specific areas of interest include outsourced services, products and manufacturing, and patient services. This broad mandate allows the flagship fund to deploy capital across various sub-sectors of the healthcare economy.
